Drug Discovery 2017 aims to bridge the gaps in approval for drug discovery and development by discussing the latest scientific breakthroughs, exploring novel technologies and approaches that can be used to overcome drug development challenges. The event will bring togehter industry leaders who will highlight future opportunities for novel therapeutic discovery including CRISPR and Cas9 technology. Some of our featured speakers include AstraZeneca, Takeda, Novartis, Merck Serono, Sanofi, Johnson & Johnson, Eli Lilly, GSK, AbbVie, and more. Early Bird: Book by 31st January to save £100.